Search results

Skip to results

Type

Type

Last updated

Last updated

Advice programme

Showing 1 result for xultophy

  1. Type 2 diabetes: insulin degludec/liraglutide (Xultophy) (ESNM60)

    Summary of the evidence on insulin degludec/liraglutide (Xultophy) for treating type 2 diabetes to inform local NHS planning and decision-making

    Evidence summary
    Published
    3 July 2015